5c5a
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==Crystal Structure of HDM2 in complex with Nutlin-3a== | |
- | + | <StructureSection load='5c5a' size='340' side='right' caption='[[5c5a]], [[Resolution|resolution]] 1.15Å' scene=''> | |
- | + | == Structural highlights == | |
- | + | <table><tr><td colspan='2'>[[5c5a]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5C5A OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5C5A FirstGlance]. <br> | |
- | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=IOD:IODIDE+ION'>IOD</scene>, <scene name='pdbligand=NUT:4-({(4S,5R)-4,5-BIS(4-CHLOROPHENYL)-2-[4-METHOXY-2-(PROPAN-2-YLOXY)PHENYL]-4,5-DIHYDRO-1H-IMIDAZOL-1-YL}CARBONYL)PIPERAZIN-2-ONE'>NUT</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | |
- | [[Category: | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5c5a FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5c5a OCA], [http://pdbe.org/5c5a PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5c5a RCSB], [http://www.ebi.ac.uk/pdbsum/5c5a PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5c5a ProSAT]</span></td></tr> |
- | [[Category: | + | </table> |
+ | == Disease == | ||
+ | [[http://www.uniprot.org/uniprot/MDM2_HUMAN MDM2_HUMAN]] Note=Seems to be amplified in certain tumors (including soft tissue sarcomas, osteosarcomas and gliomas). A higher frequency of splice variants lacking p53 binding domain sequences was found in late-stage and high-grade ovarian and bladder carcinomas. Four of the splice variants show loss of p53 binding. | ||
+ | == Function == | ||
+ | [[http://www.uniprot.org/uniprot/MDM2_HUMAN MDM2_HUMAN]] E3 ubiquitin-protein ligase that mediates ubiquitination of p53/TP53, leading to its degradation by the proteasome. Inhibits p53/TP53- and p73/TP73-mediated cell cycle arrest and apoptosis by binding its transcriptional activation domain. Also acts as an ubiquitin ligase E3 toward itself and ARRB1. Permits the nuclear export of p53/TP53. Promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma RB1 protein. Inhibits DAXX-mediated apoptosis by inducing its ubiquitination and degradation. Component of the TRIM28/KAP1-MDM2-p53/TP53 complex involved in stabilizing p53/TP53. Also component of the TRIM28/KAP1-ERBB4-MDM2 complex which links growth factor and DNA damage response pathways. Mediates ubiquitination and subsequent proteasome degradation of DYRK2 in nucleus. Ubiquitinates IGF1R and promotes it to proteasomal degradation.<ref>PMID:12821780</ref> <ref>PMID:15053880</ref> <ref>PMID:15195100</ref> <ref>PMID:16337594</ref> <ref>PMID:15632057</ref> <ref>PMID:17290220</ref> <ref>PMID:19098711</ref> <ref>PMID:19219073</ref> <ref>PMID:19965871</ref> <ref>PMID:20858735</ref> <ref>PMID:20173098</ref> | ||
+ | == References == | ||
+ | <references/> | ||
+ | __TOC__ | ||
+ | </StructureSection> | ||
+ | [[Category: Gossert, A D]] | ||
+ | [[Category: Guentert, P]] | ||
[[Category: Marsh, M]] | [[Category: Marsh, M]] | ||
+ | [[Category: Orts, J]] | ||
[[Category: Riek, R]] | [[Category: Riek, R]] | ||
- | [[Category: Orts, J]] | ||
[[Category: Vera, L]] | [[Category: Vera, L]] | ||
- | [[Category: | + | [[Category: Waelti, M A]] |
- | [[Category: | + | [[Category: Complex structure]] |
+ | [[Category: Drug design]] | ||
+ | [[Category: Hdm2]] | ||
+ | [[Category: Ligase]] |
Revision as of 10:19, 13 July 2016
Crystal Structure of HDM2 in complex with Nutlin-3a
|
Categories: Gossert, A D | Guentert, P | Marsh, M | Orts, J | Riek, R | Vera, L | Waelti, M A | Complex structure | Drug design | Hdm2 | Ligase